The high mortality rate in cancer patients is always one of the main challenges of the health systems globally. Several factors are involved in the high rate of cancer related mortality, including late diagnosis and drug resistance. Cancer is mainly diagnosed in the advanced stages of tumor progression that causes the failure of therapeutic strategies and increases the death rate in these patients. Therefore, assessment of the molecular mechanisms associated with the occurrence of cancer can be effective to introduce early tumor diagnostic markers. MicroRNAs (miRNAs) as the stable non-coding RNAs in the biological body fluids are involved in regulation of cell proliferation, migration, and apoptosis. MiR-532 deregulation has been reported in different tumor types. Therefore, in the present review we discussed the role of miR-532 during tumor growth. It has been shown that miR-532 has mainly a tumor suppressor role through the regulation of transcription factors, chemokines, and signaling pathways such as NF-kB, MAPK, PI3K/AKT, and WNT. In addition to the independent role of miR-532 in regulation of cellular processes, it also functions as a mediator of lncRNAs and circRNAs. Therefore, miR-532 can be considered as a non-invasive diagnostic/prognostic marker as well as a therapeutic target in cancer patients.
Keyphrases
- cell proliferation
- pi k akt
- cell cycle arrest
- signaling pathway
- long non coding rna
- cell cycle
- long noncoding rna
- papillary thyroid
- oxidative stress
- transcription factor
- poor prognosis
- risk factors
- newly diagnosed
- type diabetes
- immune response
- cardiovascular disease
- cardiovascular events
- coronary artery disease
- lymph node metastasis
- prognostic factors
- toll like receptor
- induced apoptosis
- nuclear factor
- network analysis
- dna binding